Tanzeum

Product NDC

0173-0866

11-digit product format

001730866

Labeler code

0173

Product ID

0173-0866_547b7089-3a91-4bb4-8881-e1abfbe39e82

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

albiglutide

Dosage form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

SUBCUTANEOUS

Labeler

GlaxoSmithKline LLC

Application

BLA125431

Marketing category

BLA

Marketing start

2014-04-15

Marketing end

2020-09-30

Substance

ALBIGLUTIDE

Active strength

30 mg/.5mL

Pharmacologic classes

Glucagon-like Peptide-1 (GLP-1) Agonists [MoA],GLP-1 Receptor Agonist [EPC]

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record